about
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transitionBiomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortalityGlobal, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Impact of age, sex, and indexation method on MR left ventricular reference values in the Framingham Heart Study offspring cohort.Subclinical and clinical correlates of left ventricular wall motion abnormalities in the community.Relationship between central and peripheral atherosclerosis and left ventricular dysfunction in a community population.Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatmentThe systolic blood pressure difference between arms and cardiovascular disease in the Framingham Heart Study.Risk factor differences in calcified and noncalcified aortic plaque: the Framingham Heart StudyDiet quality, physical activity, smoking status, and weight fluctuation are associated with weight change in women and menRelations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the communitySecular trends in echocardiographic left ventricular mass in the community: the Framingham Heart Study.Serum gamma-glutamyl transferase and risk of heart failure in the communityCardiac index is associated with brain aging: the Framingham Heart StudyTumor necrosis factor-related apoptosis-inducing ligand alters mitochondrial membrane lipids.The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern.Exercise blood pressure and the risk of incident cardiovascular disease (from the Framingham Heart Study)Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality.Multimarker approach for the prediction of heart failure incidence in the communityA multi-marker approach to predict incident CKD and microalbuminuriaAltered blood pressure progression in the community and its relation to clinical eventsMild expression of mitral valve prolapse in the Framingham offspring: expanding the phenotypic spectrum.Multiple biomarkers for the prediction of first major cardiovascular events and death.Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study.A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunctionBarriers to HIV Testing in Black Immigrants to the U.S.Cardiovascular correlates of platelet count and volume in the Framingham Heart Study.Parental intermittent claudication as risk factor for claudication in adults50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort studyDietary patterns of women are associated with incident abdominal obesity but not metabolic syndromeGlobal Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015.C-reactive protein, inflammatory conditions, and cardiovascular disease riskCorrelation of trabeculae and papillary muscles with clinical and cardiac characteristics and impact on CMR measures of LV anatomy and function.Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community.Usefulness of the left ventricular myocardial contraction fraction in healthy men and women to predict cardiovascular morbidity and mortality.Long-term C-reactive protein variability and prediction of metabolic risk.Aortic root remodeling and risk of heart failure in the Framingham Heart studyLong-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart studyPericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study.
P50
Q21034169-69E5D421-06D5-46C3-AD2F-923F3486E1D5Q24170269-5728DBFC-1811-43B2-BB22-48E26CB53030Q24623768-26E13559-7C24-4802-870E-218AF3A76E60Q30358426-CE88BE25-4DC4-4177-9889-23663E56D45BQ30387185-698ED4E3-CC30-4FB2-9A37-6CB9B083BAD6Q30469559-286ED360-3B26-4382-9C5B-D1762EB6BA44Q30471872-581F848D-739F-4F63-9D61-8086CB3687B9Q33720842-38979E42-456C-4502-B016-FD39F60F7A71Q33789485-5EB5281D-A805-43BC-A742-5718AD276575Q33904039-42737DD5-F889-4CF2-9739-68941FC701A0Q33908701-8BCE23DD-1CB9-4796-9C2A-443146A5D0C7Q34032117-147D25A3-D871-4075-9B5E-5539E3EBDEA9Q34069733-23DD748C-80D9-4423-BE70-16E0B45517B9Q34075652-3652E2D3-322B-4E5D-AC5D-38CF6ADB3C7CQ34090309-A33F2161-B772-4D41-A168-134CB0DF749BQ34139591-04633141-CD21-4F1B-8CA1-68BE21D8248EQ34179251-1D8E3B6F-BF8D-4ADF-AC0A-CE78216D5269Q34193169-77350302-3B55-4234-8D17-DC9C4797E738Q34222299-0F1EB808-D345-443C-A2D0-8342F94CF4C7Q34357369-7F9BBF21-7313-424D-A345-880D01E8F852Q34457191-296B147D-AFCA-40A7-A0EA-DAC3A060D976Q34504959-E21DB078-1D4A-48DA-BEFB-942E93E76DDEQ34554557-1CAD4604-B498-4287-A052-2C33478BAABFQ34593507-1AB6B308-E7C5-4CF6-A767-532BB68921ADQ34670148-D408D328-F154-4B26-8B3D-131402EE527FQ35627561-D028ED76-D719-44A2-95CA-59DFE36FA8B0Q35642165-257B428F-B1DD-4834-94A4-34FAD96CFA52Q35689156-80654A0A-8249-424C-BE12-E603488D1F63Q35782709-0755331A-1E9A-4A13-9CC8-43B0A308F502Q36005690-0FDE0800-D260-489E-ACD5-49BDE64A259AQ36160335-D4DA7DC0-8D8C-42FF-AD1A-E03026AA64A9Q36252176-E8BEA447-1A3F-4390-9BE4-339649C498CCQ36408376-B555E395-A5DC-418E-A4E5-107C625D3201Q36411354-1E0C8B68-D67A-4557-9D60-05DC7FAC45A5Q36489384-242EDAB9-5B3D-4F64-9BE9-5181D8D4EBE6Q37091498-8A92356A-AC6F-44B3-9E92-26444A7A91A4Q37125113-9B70CCAD-5620-40A2-97F9-5EF938F190BDQ37128296-F46AD7D7-515D-463F-8EAD-F5661DB4E233Q37301547-3E6DE1F3-6C73-46D1-B51D-0B86EF339CD7Q37306721-013B14B0-60C2-4146-9185-2236A09477F8
P50
description
Associate professor of Biostatistics
@en
wetenschapper
@nl
name
Philimon Gona
@ast
Philimon Gona
@en
Philimon Gona
@es
Philimon Gona
@nl
Philimon Gona
@sl
type
label
Philimon Gona
@ast
Philimon Gona
@en
Philimon Gona
@es
Philimon Gona
@nl
Philimon Gona
@sl
prefLabel
Philimon Gona
@ast
Philimon Gona
@en
Philimon Gona
@es
Philimon Gona
@nl
Philimon Gona
@sl
P106
P1960
rnQJ-dUAAAAJ
P21
P31
P496
0000-0002-4202-5965